Keratoconus significantly impacts patients' quality of life. Conventional management often leaves unmet visual needs. Wavefront-guided scleral lenses (wfgSL) and Corneal Tissue Addition Keratoplasty (CTAK) represent the 2 newest advancements in keratoconus management. This evidence and case based guide will provide practitioners with the clinical considerations to confidently select appropriate candidates, manage expectations, understand the science and procedure for each, as well as know the expected outcomes. After this course the practitioner should be able to confidently incorporate these innovations into clinical practice, or at least be aware of their existence, as part of the management of the keratoconus patient.
Over 1000 attended our event and we received amazing feedback!
Feedback from anonymous survey:
Woo U is fantastic. Thank you for this education session.
Very interesting and I learned a lot about these innovative treatments and techniques. Thanks!
Excellent presentation! Loved having both a surgical and nonsurgical approach to KCS!
Thank you. A very informative session we had today.
Wow - what a great team, as well as combination topics.
Very clear presentation! Enjoyed the video of the surgery! Always great to have 2 speakers!
Thank you for this wonderful learning opportunity!
Very good pictures and videos! Thank you!
Great presentation. Awesome new treatment options.
Speakers: John Gelles, OD and Steven Greenstein, MD
Moderator: Dr. Jennifer Stewart
COPE ID: 97608-TD
Category: Trt/Mngmnt Ocular Disease
This event is COPE approved for 1 hour of CE credit.
Corneal Tissue Addition for Keratoplasty - CTAK offers an advanced solution for contouring keratoconic eyes to significantly improve sight for patients in need. Using CorneaGen’s Custom Tissue Inlays, CTAK provides patient-ready, gamma-irradiated sterile, non‑immunogenic donated corneal tissue inlays that are laser-cut and customized to patients’ specific severity and cone location.
Thank you to CorneaGen for exhibiting at this event.